Will untreated osteosarcoma shorten lifespan?

Many patients think that osteosarcoma is a death warrant. Now that good treatment results have been achieved, patients need to overcome their fear. However, the huge medical expenses are also a huge burden on the family, which makes patients anxious. Now let's talk about whether untreated osteosarcoma will shorten life expectancy:

Osteosarcoma should be treated surgically whenever possible. Surgery must be radically removed to avoid local recurrence. At present, limb salvage has become the main surgical procedure for osteosarcoma, but when limb salvage is not suitable or unconditional, amputation should be performed decisively. Chemotherapy is not necessary before surgery, but standardized chemotherapy must be performed after surgery. The characteristic of osteosarcoma is that tumor cells directly form bone-like tissue, so it is also called osteosarcoma, but osteosarcoma cannot be ruled out even if the tumor's bone formation process is not obvious. The survival period of bone cancer patients generally has three years of survival, five years of survival, and ten years of survival, which refers to survival of three years, five years, and more than ten years after surgery, respectively. The medical community has its corresponding cure standards for different degrees of cancer. Regarding the issue of patient survival, it also depends on the individual. Some people with better postoperative results can live like normal people, and can live to 70, 80 years old or even older like normal people. For the treatment of cancer, the key lies in early detection and the patient's positive attitude.

However, due to the emergence of neoadjuvant chemotherapy, especially with adequate doses and reasonable regimens, the survival rate has been significantly improved. The efficacy of osteosarcoma is evaluated by the statistical 5-year survival rate. Under the most scientific and reasonable treatment, the 5-year survival rate of osteosarcoma can reach more than 70%, and patients who live for more than 5 years have a more than 90% chance of long-term survival. From our experience, osteosarcoma is most likely to recur and metastasize within 2 years after treatment. If there is no recurrence and metastasis within 2 years, it is basically possible to control it. The recurrence rate five years after surgery is relatively high. Regular follow-up and regular medication are required after surgery. The difficulty of tumor treatment lies in the easy recurrence and metastasis. Patients can take anti-cancer Chinese patent medicine oral liquid, which is safe, inhibits and eliminates tumors while improving immunity, regulating internal balance, and fundamentally preventing recurrence and metastasis.

Some osteosarcoma patients fail to detect their condition after recurrence and miss the best time for treatment, which leads to worsening of the condition. At this time, their lives may be in danger at any time. The treatment of osteosarcoma recurrence is the same as the treatment of osteosarcoma. It is important to take systematic treatment in the early stage and pay attention to the psychological care of patients with osteosarcoma recurrence.

Osteosarcoma is still a malignant tumor with a high mortality rate in children and adolescents, but early detection and timely treatment have greatly improved the survival rate of the disease.

So when people ask whether osteosarcoma will affect life expectancy, the answer is that depending on treatment and various immune factors from the body, life will continue tenaciously. However, if it is not treated, osteosarcoma cells will metastasize to the lungs, and life will be directly affected.